• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活转录因子 3 通过抑制 JunB 抑制子宫内膜癌的侵袭性。

Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression.

机构信息

Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.

School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.

出版信息

Int J Oncol. 2020 Sep;57(3):707-720. doi: 10.3892/ijo.2020.5084. Epub 2020 Jun 19.

DOI:10.3892/ijo.2020.5084
PMID:32582999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7384851/
Abstract

The function of activating transcription factor 3 (ATF3) in cancer is context‑dependent and its role in endometrial carcinoma (EC) is yet to be elucidated. In the present study, ATF3 was indicated to be downregulated, while one of the ATF3‑interacting proteins, JunB, was upregulated in ECs according to western blot analysis. After overexpression in ECs, ATF3 inhibited the proliferation and invasion of EC cells and enhanced apoptosis, as well as suppressed the expression of JunB. The properties of EC cells, including the expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, the cell cycle and apoptosis were all altered by overexpression of ATF3. Furthermore, luciferase activity assay, chromatin precipitation and DNA affinity assay results indicated that ATF3 exerted the aforementioned functions via JunB binding and activator protein‑1 signaling. However, the interaction between ATF3 and JunB did not occur in EC cells under basal conditions, but in ATF3‑overexpressing ECs, which was capable of mitigating EC proliferation, invasion and metastasis. Collectively, the present results suggested that the ATF3/JunB interaction may serve as a potential therapeutic target for ECs.

摘要

激活转录因子 3(ATF3)在癌症中的功能具有上下文依赖性,其在子宫内膜癌(EC)中的作用尚待阐明。在本研究中,根据 Western blot 分析表明,ATF3 在 EC 中呈下调表达,而 ATF3 相互作用蛋白之一 JunB 呈上调表达。在 EC 中过表达后,ATF3 抑制 EC 细胞的增殖和侵袭,并促进细胞凋亡,同时抑制 JunB 的表达。EC 细胞的特性,包括基质金属蛋白酶和金属蛋白酶组织抑制剂的表达、细胞周期和凋亡均通过 ATF3 的过表达而改变。此外,荧光素酶活性测定、染色质沉淀和 DNA 亲和测定结果表明,ATF3 通过 JunB 结合和激活蛋白-1 信号传导发挥上述功能。然而,在基础条件下,ATF3 和 JunB 之间的相互作用不会发生在 EC 细胞中,而是在过表达 ATF3 的 EC 细胞中发生,这能够减轻 EC 的增殖、侵袭和转移。综上所述,本研究结果表明,ATF3/JunB 相互作用可能成为 EC 的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/74393402bbe2/IJO-57-03-0707-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/e5e4b9a755ba/IJO-57-03-0707-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/2e3a1f818d02/IJO-57-03-0707-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/cbb835b165e6/IJO-57-03-0707-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/c25302e34d85/IJO-57-03-0707-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/170c571fa779/IJO-57-03-0707-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/74393402bbe2/IJO-57-03-0707-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/e5e4b9a755ba/IJO-57-03-0707-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/2e3a1f818d02/IJO-57-03-0707-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/cbb835b165e6/IJO-57-03-0707-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/c25302e34d85/IJO-57-03-0707-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/170c571fa779/IJO-57-03-0707-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bd/7384851/74393402bbe2/IJO-57-03-0707-g05.jpg

相似文献

1
Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression.激活转录因子 3 通过抑制 JunB 抑制子宫内膜癌的侵袭性。
Int J Oncol. 2020 Sep;57(3):707-720. doi: 10.3892/ijo.2020.5084. Epub 2020 Jun 19.
2
Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics.基于网络药理学和转录组学揭示急性子乙酸乙酯提取物抗前列腺癌的作用机制。
J Ethnopharmacol. 2024 Aug 10;330:118228. doi: 10.1016/j.jep.2024.118228. Epub 2024 Apr 19.
3
Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.半胱天冬酶切割 JunB 转录因子生成羧基末端片段,抑制激活蛋白-1 的转录活性。
J Biol Chem. 2013 Jul 26;288(30):21482-95. doi: 10.1074/jbc.M113.485672. Epub 2013 Jun 9.
4
Transcription factor ATF3 mediates the radioresistance of breast cancer.转录因子 ATF3 介导乳腺癌的放射抵抗性。
J Cell Mol Med. 2018 Oct;22(10):4664-4675. doi: 10.1111/jcmm.13688. Epub 2018 Aug 17.
5
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.miR-29a-5p 通过靶向 TPX2 抑制子宫内膜癌细胞增殖、侵袭并诱导其凋亡。
Cell Cycle. 2018;17(10):1268-1278. doi: 10.1080/15384101.2018.1475829. Epub 2018 Jul 23.
6
MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.微小RNA-505通过靶向转化生长因子-α发挥子宫内膜癌抑癌基因的作用。
Mol Cancer. 2016 Feb 2;15:11. doi: 10.1186/s12943-016-0496-4.
7
ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.转录激活因子 3 通过上调细胞因子反应元件 61 的表达抑制肝癌细胞的肿瘤发生和进展。
J Exp Clin Cancer Res. 2018 Oct 30;37(1):263. doi: 10.1186/s13046-018-0919-8.
8
ATF3 downmodulates its new targets IFI6 and IFI27 to suppress the growth and migration of tongue squamous cell carcinoma cells.ATF3 下调其新靶标 IFI6 和 IFI27,抑制舌鳞癌细胞的生长和迁移。
PLoS Genet. 2021 Feb 4;17(2):e1009283. doi: 10.1371/journal.pgen.1009283. eCollection 2021 Feb.
9
Potential Dual Role of Activating Transcription Factor 3 in Colorectal Cancer.转录激活因子3在结直肠癌中的潜在双重作用
Anticancer Res. 2016 Feb;36(2):509-16.
10
Activating transcription factor 3 promotes malignance of lung cancer cells in vitro.激活转录因子 3 促进肺癌细胞的体外恶性转化。
Thorac Cancer. 2017 May;8(3):181-191. doi: 10.1111/1759-7714.12421. Epub 2017 Feb 27.

引用本文的文献

1
Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner.RvD1和RvD2以受体依赖方式促进肺部炎症消退。
Pharmaceutics. 2023 May 18;15(5):1527. doi: 10.3390/pharmaceutics15051527.
2
Identification of Key Endometrial MicroRNAs and Their Target Genes Associated With Pathogenesis of Recurrent Implantation Failure by Integrated Bioinformatics Analysis.通过综合生物信息学分析鉴定与反复种植失败发病机制相关的关键子宫内膜微小RNA及其靶基因
Front Genet. 2022 Jun 22;13:919301. doi: 10.3389/fgene.2022.919301. eCollection 2022.
3
Identification and Validation of ATF3 Serving as a Potential Biomarker and Correlating With Pharmacotherapy Response and Immune Infiltration Characteristics in Rheumatoid Arthritis.

本文引用的文献

1
Corrigendum to "Revised FIGO staging for carcinoma of the cervix uteri" [Int J Gynecol Obstet 145(2019) 129-135].《子宫颈癌的FIGO分期修订版》勘误[《国际妇产科杂志》145(2019) 129 - 135]
Int J Gynaecol Obstet. 2019 Nov;147(2):279-280. doi: 10.1002/ijgo.12969.
2
Current recommendations and recent progress in endometrial cancer.子宫内膜癌的当前建议和最新进展。
CA Cancer J Clin. 2019 Jul;69(4):258-279. doi: 10.3322/caac.21561. Epub 2019 May 10.
3
Cancer statistics, 2019.癌症统计数据,2019 年。
ATF3作为类风湿关节炎潜在生物标志物的鉴定与验证及其与药物治疗反应和免疫浸润特征的相关性
Front Mol Biosci. 2021 Dec 13;8:761841. doi: 10.3389/fmolb.2021.761841. eCollection 2021.
4
Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.应激诱导乙酰肝素酶 2(Hpa2)的表达是由 ATF3 介导的。
Matrix Biol. 2022 Jan;105:17-30. doi: 10.1016/j.matbio.2021.11.001. Epub 2021 Nov 20.
5
ATF3 deficiency impairs the proliferative-secretory phase transition and decidualization in RIF patients.ATF3 缺乏可损害 RIF 患者的增殖-分泌期转换和蜕膜化。
Cell Death Dis. 2021 Apr 12;12(4):387. doi: 10.1038/s41419-021-03679-8.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB.LINC00657通过靶向miR-615-3p和JunB在食管鳞状细胞癌中发挥致癌作用。
Biomed Pharmacother. 2018 Dec;108:316-324. doi: 10.1016/j.biopha.2018.09.003. Epub 2018 Sep 15.
5
Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions.激活转录因子 3 及其相互作用蛋白在生理和病理条件下的作用。
Int J Biol Macromol. 2018 Dec;120(Pt A):310-317. doi: 10.1016/j.ijbiomac.2018.08.107. Epub 2018 Aug 23.
6
The stress response gene ATF3 is a direct target of the Wnt/β-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells.应激反应基因 ATF3 是 Wnt/β-连环蛋白通路的直接靶标,抑制 HCT116 人结直肠癌细胞的侵袭和迁移。
PLoS One. 2018 Jul 2;13(7):e0194160. doi: 10.1371/journal.pone.0194160. eCollection 2018.
7
Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.异常表达的 JunB 通过 IL-6/STAT3 信号转导促进葡萄膜黑色素瘤的侵袭转移能力通过上皮间质转化。
Biosci Rep. 2018 Jul 2;38(4). doi: 10.1042/BSR20180532. Print 2018 Aug 31.
8
RAC2 promotes abnormal proliferation of quiescent cells by enhanced JUNB expression via the MAL-SRF pathway.RAC2 通过 MAL-SRF 通路增强 JUNB 表达促进静止细胞异常增殖。
Cell Cycle. 2018;17(9):1115-1123. doi: 10.1080/15384101.2018.1480217. Epub 2018 Jul 9.
9
Hijacking of the AP-1 Signaling Pathway during Development of ATL.成人T细胞白血病(ATL)发展过程中AP-1信号通路的劫持
Front Microbiol. 2018 Jan 15;8:2686. doi: 10.3389/fmicb.2017.02686. eCollection 2017.
10
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion.JUNB 调控 TGFβ 信号的前馈网络,从而加重乳腺癌的侵袭。
Nucleic Acids Res. 2018 Feb 16;46(3):1180-1195. doi: 10.1093/nar/gkx1190.